Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bodenheimer

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
The American Journal of Gastroenterology|April 22, 2005
Evaluation of fatigue in U.S. patients with primary biliary cirrhosisCarmen M Stanca, Nancy Bach, Cynthia Krause, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 1999
Hereditary hemochromatosis in liver transplantationM I Fiel, T D Schiano, H C Bodenheimer, et al.
Hepatology (Baltimore, Md.)|September 10, 1998
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantationP A Sheiner, P Boros, F M Klion, et al.
The New England Journal of Medicine|August 2, 1990
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy GroupR P Perrillo, E R Schiff, G L Davis, et al.
Hepatology (Baltimore, Md.)|November 1, 1996
Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy GroupK L Lindsay, G L Davis, E R Schiff, et al.
American Journal of Public Health|August 17, 2013
A randomized trial of a hepatitis care coordination model in methadone maintenance treatmentCarmen L Masson, Kevin L Delucchi, Courtney McKnight, et al.
The American Journal of Gastroenterology|November 11, 2005
A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis CIra M Jacobson, Stevan A Gonzalez, Furqaan Ahmed, et al.
Human Molecular Genetics|September 1, 2012
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variantsBrian D Juran, Gideon M Hirschfield, Pietro Invernizzi, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
The American Journal of Gastroenterology|April 22, 2005
Evaluation of fatigue in U.S. patients with primary biliary cirrhosisCarmen M Stanca, Nancy Bach, Cynthia Krause, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 1999
Hereditary hemochromatosis in liver transplantationM I Fiel, T D Schiano, H C Bodenheimer, et al.
Hepatology (Baltimore, Md.)|September 10, 1998
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantationP A Sheiner, P Boros, F M Klion, et al.
The New England Journal of Medicine|August 2, 1990
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy GroupR P Perrillo, E R Schiff, G L Davis, et al.
Hepatology (Baltimore, Md.)|November 1, 1996
Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy GroupK L Lindsay, G L Davis, E R Schiff, et al.
American Journal of Public Health|August 17, 2013
A randomized trial of a hepatitis care coordination model in methadone maintenance treatmentCarmen L Masson, Kevin L Delucchi, Courtney McKnight, et al.
The American Journal of Gastroenterology|November 11, 2005
A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis CIra M Jacobson, Stevan A Gonzalez, Furqaan Ahmed, et al.
Human Molecular Genetics|September 1, 2012
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variantsBrian D Juran, Gideon M Hirschfield, Pietro Invernizzi, et al.
Pageof 7